Behçet's Disease and Cosmetic Surgery: Pathergy, Mouth Ulcers, Fillers, Microneedling, Eye Inflammation, Blood Clots, Apremilast, and Biologics

She is 38 and has two requests. She wants a little more definition in her upper lip, and she wants microneedling for a scatter of bumps along her jaw and chin that she calls adult acne. On the intake form, under medical history, she writes "canker sores, bad ones." Asked to say more, she mentions that she has had painful mouth ulcers several times a year since her twenties, that she once had tender red lumps on her shins that a walk-in clinic called a bruise, and that last spring one eye turned red and blurry for two weeks before an eye doctor gave her drops. She thinks of these as unrelated nuisances. She has read about the difference between a lip lift and lip filler and has a booking in mind.

A careful injector hears that list and stops. Recurrent, painful mouth ulcers, acne-like bumps in places adult acne does not usually favor, tender nodules on the shins, and an episode of eye inflammation is a pattern that should prompt one question before any other: has anyone ever considered Behçet's disease? It is uncommon in the United States, and many patients go years without a name for what is happening to them. But it has a feature that matters more to cosmetic medicine than almost any other autoimmune trait. In some patients, a simple needle prick can trigger an inflammatory reaction in the skin. This piece covers what Behçet's disease is, how that reactivity affects fillers, microneedling, and surgery, why the eyes and the veins come first, and what a reasonable plan looks like once the disease is controlled.

Behçet's disease and cosmetic surgery: what the disease is and why it hides

The short answer: Behçet's disease is a chronic inflammatory disorder of blood vessels of every size, recognized mostly by recurrent mouth and genital ulcers, skin lesions, and eye inflammation, and because its early signs look like canker sores and acne, it is often missed for years.

Behçet's disease is classified as a variable-vessel vasculitis in the 2012 revised Chapel Hill consensus nomenclature, meaning it can inflame arteries and veins of any size, anywhere in the body. That distinguishes it from most vasculitides, which tend to favor one type of vessel. Its cause is not fully understood. It has a strong association with the genetic marker HLA-B51, and it clusters along the old Silk Road trade routes from the Mediterranean through the Middle East to East Asia. Turkey reports the highest prevalence in the world, with some surveys finding a few hundred cases per 100,000 adults. In the United States it is rare, with estimates in the range of a few cases per 100,000 people, which is one reason it is so often unrecognized. It usually begins in the twenties or thirties, the same years many people start thinking about lips, skin, and bodies.

The features that bring people to a cosmetic office are the mucocutaneous ones:

• Oral ulcers. Recurrent painful ulcers on the lips, gums, tongue, and inside of the cheeks are the most common sign, present in nearly every patient. They look like ordinary canker sores but tend to be more frequent, more numerous, and slower to heal.
• Genital ulcers. Deeper and more painful than the oral ones, and more likely to leave scars. They are often the most specific clue.
• Papulopustular lesions. Acne-like bumps and pustules, sometimes in locations where acne is unusual, such as the arms and legs. They are easy to mistake for breakouts and are a common reason for a misdirected skin care consultation, including requests for treatments described in the piece on acne scar treatment.
• Erythema nodosum-like lesions. Tender red nodules, usually on the shins, that fade like bruises.
• Superficial thrombophlebitis. Inflamed, cord-like veins under the skin, often on the legs, which can look like erythema nodosum and which are a clue to the vascular side of the disease.

There is no single blood test for Behçet's. The diagnosis is clinical, built on the pattern. The widely used International Criteria for Behçet's Disease (ICBD), published in 2014, assign points to oral ulcers, genital ulcers, and eye disease (two points each) and to skin lesions, neurological involvement, vascular involvement, and a positive pathergy test (one point each), with four points generally considered diagnostic. The older 1990 International Study Group criteria required recurrent oral ulcers plus two other features. Either way, the person in the opening paragraph scores enough on history alone to warrant a referral to a rheumatologist or dermatologist with experience in the disease.

The broader framework for autoimmune disease before elective surgery is covered in the piece on cosmetic surgery with autoimmune disease. Behçet's deserves its own treatment because of one trait no other common autoimmune disease shares to the same degree: the skin's reaction to being punctured.

Pathergy: why a needle prick matters more here than almost anywhere else

The short answer: many people with Behçet's disease have pathergy, an exaggerated inflammatory response to minor skin trauma, so injections, microneedling, and incisions can produce pustules, nodules, or ulcers at the treated sites, and the risk has to be weighed before any needle touches the skin.

The pathergy test is old and simple. A sterile needle is inserted into the skin of the forearm, and the site is examined 24 to 48 hours later. A positive result is a small red papule or pustule at the puncture site, an inflammatory reaction out of all proportion to the injury. It is not an infection. The pustule is sterile. It reflects an immune system that treats minor trauma as a signal to mount a response.

Two facts about pathergy are important for anyone weighing cosmetic treatment. First, its frequency varies enormously by geography. Positive tests are common in patients from Turkey, the Middle East, and Japan and considerably less common in patients from northern Europe and North America. A negative pathergy test does not rule out the disease, and a person of any background with Behçet's should assume the trait may be present until there is reason to think otherwise. Second, pathergy positivity appears to have declined over the decades, and studies have linked that decline partly to the use of disposable sharp needles and to cleaning the skin before puncture. Technique, in other words, modifies the response. That is useful information for planning.

What does pathergy mean for cosmetic procedures? The honest answer is that the published evidence on aesthetic treatments in Behçet's is thin, and much of what follows is inference from the known biology and from surgical experience in the disease. With that caveat:

• Fillers. A filler session involves several to dozens of needle or cannula entry points, plus a foreign material placed under the skin. In a person with active pathergy, each entry point is a potential site for a sterile pustule or nodule, and an inflamed nodule near filler can be difficult to distinguish from the reactions described in the piece on delayed filler nodules. Cannulas, which use fewer entry points than needles, are a reasonable consideration. Hyaluronic acid has the advantage of being reversible, as the piece on dissolving dermal filler explains, which matters more than usual here. Permanent or semi-permanent products and the biostimulatory fillers that work by provoking inflammation and collagen deposition are a different proposition in a disease defined by inflammatory overreaction, and most experienced clinicians would be wary of them.
• Microneedling and PRP. Microneedling creates hundreds or thousands of controlled punctures in a single session. In a patient with strong pathergy, that is close to a deliberate provocation test over the entire face. Combining it with platelet-rich plasma, discussed in the piece on the vampire facial and PRP, adds nothing to reduce that risk. This is the one procedure on the opening patient's list that deserves a firm "not yet," and possibly "not at all," until her diagnosis is settled.
• Neurotoxins. Botox and similar products use very few, very fine needle sticks and place no lasting material in the skin. Of the injectable options, they are probably the lowest pathergy exposure, though an injector should still ask about and document any prior reactions at needle sites.
• Threads. Barbed threads combine multiple punctures with a foreign body left in the tissue for months. The case against them in the general population, made in the piece on PDO thread lifts, is only stronger here.
• Tattooing and permanent makeup. Lip blushing and brow tattooing are, mechanically, thousands of needle punctures carrying pigment. The same concerns apply.

"Behçet's disease is the rare diagnosis in which a microneedling session can be more provocative than a facelift incision. The question is not how big the procedure is. It is how many times the skin is punctured and how active the disease is when it happens."

A practical approach many clinicians use for any needle-based treatment in a person with Behçet's: confirm the disease is quiet, ask directly about past reactions at blood draw or injection sites, prepare the skin with antiseptic, use fresh sharp needles and the fewest entry points the treatment allows, and consider a single test site or a small first session before committing to a full treatment. If pustules or nodules appear at the test site within a day or two, that is an answer.

Mouth ulcers, lips, and the face: injecting and operating where the disease lives

The short answer: active oral ulcers are a reason to postpone any lip or perioral injection, dental work and minor oral trauma can trigger new ulcers, and facial procedures should be timed for a quiet period with a plan for what happens if a flare follows.

The lips, the gums, and the inside of the mouth are where Behçet's most often shows itself, and they are also where lip filler, the Botox lip flip, and perioral rejuvenation are performed. A few principles follow:

• Never inject through or next to an active ulcer. An open ulcer is a break in the mucosa with inflamed tissue around it. Placing filler beside it invites infection and inflammation and makes any problem that follows hard to diagnose. Wait until the mouth is clear.
• Expect that trauma may trigger ulcers. Many patients with Behçet's report that dental cleanings, dental procedures, biting the cheek, or even a hard toothbrush provoke new ulcers. Injections and retraction of the lips during a procedure are similar forms of minor trauma. A patient with a known pattern should have a plan in hand, typically a topical steroid or the medication her specialist already uses for flares, before a perioral treatment, not after.
• Coordinate with dental work. The scheduling questions in the piece on dental work and facial cosmetic procedures apply with extra force. Stacking a dental procedure and a lip injection in the same week doubles the provocation.
• Distinguish a flare from a complication. Swelling, a tender bump, or a sore near an injection site in a person with Behçet's could be pathergy, a new ulcer, a filler reaction, an infection, or, rarely, the early sign of compromised blood flow. That last possibility, covered in the piece on filler vascular occlusion, is an emergency in anyone, and an injector should not assume that a painful blanching area is "just Behçet's." The disease does not protect against ordinary complications. It adds more things they can be confused with.

Surgery on the face follows the same logic. Incisions in a person with active pathergy can, in principle, develop pustules along the suture line or heal with more inflammation than expected. In practice, many patients with well-controlled disease undergo surgery without trouble, but meticulous technique, fine sutures removed on time, careful wound care, and a low threshold to involve the treating specialist if the wound misbehaves are all reasonable. The general principles in the piece on scar care after plastic surgery apply, with the added caution that steroid injections into a scar, sometimes used for thick scars, should be coordinated with whoever manages the disease. Wound breakdown, discussed in the piece on wound dehiscence, should prompt the question of whether an ulcer is forming in the incision.

Severe, longstanding Behçet's can scar the soft palate or throat in a minority of patients. That matters for anesthesia: an anesthesiologist planning intubation should know about any history of throat ulcers, voice changes, or difficulty swallowing, and should be told that the patient's mouth and airway may react to instrumentation with new ulcers in the days after surgery.

The eyes and the veins: the two things that must be cleared before anything elective

The short answer: Behçet's uveitis can cause permanent vision loss and needs an ophthalmologist's review before eyelid or facial surgery, and Behçet's-related blood clots arise from inflamed vessel walls rather than ordinary clotting problems, which makes clot prevention around body contouring surgery more complicated than usual.

The eyes. Eye involvement occurs in a substantial share of patients, more often and more severely in young men. It usually takes the form of uveitis, inflammation inside the eye, and the most dangerous variety involves the back of the eye: retinal vasculitis that, untreated or undertreated, can cause permanent loss of vision. Attacks can be sudden and recurrent. The 2018 update of the European Alliance of Associations for Rheumatology (EULAR) recommendations for Behçet's treats eye disease as a serious, organ-threatening manifestation requiring systemic immunosuppression, often with azathioprine, cyclosporine, interferon alpha, or anti-TNF drugs such as infliximab and adalimumab.

The opening patient's red, blurry eye may have been uveitis rather than the conjunctivitis it was treated as. For cosmetic surgery, the implications are direct. Anyone with Behçet's who wants blepharoplasty, a brow lift, or a facelift should have a recent examination by an ophthalmologist who knows the history. Postoperative redness, swelling, and irritation around the eye are normal after eyelid surgery, and the dry eye discussed in the piece on dry eye after eyelid surgery is common. In a person with Behçet's, those ordinary symptoms can mask an attack of uveitis. Any new blurred vision, light sensitivity, floaters, or eye pain after surgery should be treated as a possible flare and examined promptly, not dismissed as recovery. The coordination principles in the piece on eye surgery and blepharoplasty timing are a useful template.

The veins. Vascular involvement is one of the most serious aspects of Behçet's, and venous thrombosis is its most common form: superficial thrombophlebitis, deep vein thrombosis in the legs, and less commonly clots in large veins such as the vena cava or the hepatic veins. These clots behave differently from ordinary ones. They are driven by inflammation of the vein wall, the clot tends to stick firmly to that wall, and they recur. For that reason the EULAR recommendations put immunosuppression, typically glucocorticoids with azathioprine, cyclosporine, or cyclophosphamide, at the center of treatment for Behçet's-related deep vein thrombosis, with anticoagulation a more debated addition. One specific danger shapes that debate: Behçet's can cause aneurysms of the pulmonary arteries, which can bleed catastrophically, and anticoagulating a patient with an undetected pulmonary artery aneurysm is hazardous. Arterial aneurysms can also form at sites of arterial puncture or surgical repair, a pathergy-like response in the vessel wall.

For body contouring, this is where Behçet's moves from a skin issue to a planning issue:

• Clot risk. Liposuction, tummy tucks, and combined procedures already carry a meaningful risk of venous thromboembolism, as the piece on blood clots after plastic surgery explains. A personal history of Behçet's-related thrombosis raises that risk substantially and is a strong argument for shorter procedures, avoiding combined operations, early walking, and a clot prevention plan written jointly with the specialist who manages the disease.
• Anticoagulants. A patient already on a blood thinner faces the bleeding and hematoma questions covered in the piece on blood thinners before cosmetic surgery. Stopping one in a person with recurrent inflammatory clots is not a decision a cosmetic surgeon should make alone.
• Leg procedures. Superficial thrombophlebitis and erythema nodosum both favor the legs. Liposuction of the thighs, knees, or calves in someone with active leg lesions is a poor idea, and lumps on the legs after surgery need to be evaluated rather than massaged.
• Unnecessary punctures. Arterial lines and repeated needle sticks for blood draws should be minimized. An anesthesiologist who knows the diagnosis can plan for that.

Colchicine, apremilast, steroids, and biologics: the medication plan around surgery

The short answer: most people with Behçet's take colchicine, apremilast, steroids, a conventional immunosuppressant, a biologic, or a combination, and each needs a deliberate decision about whether to continue, adjust, or time around surgery, made jointly by the surgeon and the treating specialist.

Treatment of Behçet's is tailored to which organs are involved. Mouth and skin disease is typically treated with topical steroids and colchicine, and in 2019 the FDA approved apremilast (Otezla) for oral ulcers associated with Behçet's disease in adults, based on a randomized trial showing fewer and less painful ulcers. Eye, vascular, neurological, and gut involvement call for stronger systemic treatment, including glucocorticoids, azathioprine, cyclosporine, interferon alpha, and anti-TNF biologics. Each matters for surgery:

• Colchicine. Colchicine is generally continued through minor procedures, but it has an important interaction problem. Certain antibiotics, notably clarithromycin and erythromycin, and some antifungal drugs block its breakdown and can push it to toxic levels, a risk discussed in the piece on gout, colchicine, and cosmetic surgery. Anyone on colchicine should make sure every prescriber, including whoever writes the antibiotics after cosmetic surgery, knows they take it.
• Apremilast. Apremilast is an oral drug that dampens inflammation without broadly suppressing the immune system, and perioperative guidance from the American College of Rheumatology for joint replacement surgery has generally supported continuing it. Its common side effects, including nausea, diarrhea, and weight loss, are worth noting for anyone planning body contouring around a stable weight.
• Steroids. Long-term glucocorticoids slow healing, thin the skin, raise infection risk, and can suppress the adrenal response to surgical stress, the same issue discussed in the piece on Addison's disease and stress-dose steroids. The short steroid courses some surgeons use for swelling, covered in the piece on steroids for swelling after plastic surgery, should be coordinated with whoever already manages the patient's dose.
• Azathioprine and cyclosporine. Conventional immunosuppressants used for eye and vascular disease raise infection risk to varying degrees. Cyclosporine can raise blood pressure and affect kidney function, and it is avoided in patients with neurological Behçet's. Decisions about holding these drugs before surgery depend on why they were started: a drug protecting an eye from blindness is not one to stop casually for an elective operation.
• Biologics. Infliximab and adalimumab are used for severe eye, vascular, and gut disease. The general approach in perioperative rheumatology guidance is to schedule surgery near the end of a dosing interval rather than stopping the drug for long periods, the same strategy described in the pieces on psoriasis and cosmetic surgery and Crohn's disease, ulcerative colitis, and cosmetic surgery. That last piece is also relevant for another reason: Behçet's can involve the intestine, with ulcers that resemble Crohn's disease, and abdominal pain or bleeding should not be explained away before a tummy tuck.

Smoking deserves a brief note. Behçet's is unusual in that some patients report their mouth ulcers worsen after they stop smoking. That is not a reason to keep smoking before surgery, where nicotine's effect on blood flow to skin flaps is well established and the timelines in the piece on quitting smoking before surgery still apply. It is a reason to warn patients that quitting may bring a temporary ulcer flare and to have treatment ready.

Finally, timing. Behçet's tends to be most active in the first several years after onset and often becomes milder with time, especially its mucocutaneous features. A person in the middle of an active phase, with frequent ulcers, new skin lesions, or recent eye or vascular events, is not a candidate for elective surgery. A person whose disease has been quiet for many months on a stable regimen often is, with the precautions above. A second consultation with a surgeon who has worked alongside rheumatologists is worth the time if the first surgeon has never heard of pathergy.

The honest summary

Behçet's disease does not rule out cosmetic treatment, but it rearranges the usual assumptions about what is minor. Its early signs, recurrent mouth ulcers, acne-like bumps, tender nodules on the shins, and a red eye, are easy to dismiss one at a time, and a patient who brings that history to a cosmetic consultation deserves to be asked whether anyone has considered the diagnosis before anyone discusses lips or lasers. The trait that matters most to cosmetic medicine is pathergy: in many patients, the skin can respond to a needle prick with a sterile pustule or nodule. That makes the number of punctures, not the size of the operation, a central part of the risk. Microneedling, threads, and tattooing are the procedures most at odds with the disease, biostimulatory fillers deserve caution, reversible hyaluronic acid filler and neurotoxins are more manageable, and any needle-based treatment should follow a quiet period, careful skin preparation, and possibly a test site.

The serious stakes lie elsewhere. Behçet's uveitis can take vision, so anyone planning eyelid or facial surgery needs a recent ophthalmology review and a clear plan for recognizing an eye flare after surgery. Behçet's clots come from inflamed vein walls, recur, and are treated differently from ordinary clots, and a history of thrombosis turns liposuction and tummy tucks into procedures that need a jointly written clot prevention plan. The medications, from colchicine to biologics, each need a decision made with the treating specialist, with particular attention to colchicine's antibiotic interactions and to drugs that are protecting an eye. A patient with controlled disease, a current eye exam, a clear medication plan, and a surgeon willing to talk to her rheumatologist can often do well. A patient who has never been told why her mouth keeps ulcerating needs a diagnosis first, and the most useful thing a cosmetic practice can do for her is notice.